Data & Analytics
Stuart Ingis on the benefits of showing the public how advertisers and marketers use data and creating a global regulatory framework.
Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.
At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.
Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.
Sundeep Bhan is cofounder and CEO of Prognos.
Wout Brusselaers is CEO of Deep 6 AI.
Amy Foley is VP, product innovation and delivery at Johnson & Johnson.
Cliff Jones is CEO of AllazoHealth.
Duncan Arbour is SVP of innovation at Syneos Health Communications.
Susan Dorfman is chief commercial officer of CMI/Compas.
Greg Matthews is managing director, healthcare and founder, MDigitalLife at W2O Group.
Donna Murphy is global CEO of Havas Health & You.
Marcus Sigurdsson is global chief digital officer of McCann Health.
Those on the vanguard of transformation include a number of upstarts and veteran gurus taking on historic challenges plaguing health data.
The strong start to 2018 means the firm is on track to hit financial targets for the year, said Michael Roth.
Caregivers and patients predict how the use of AI will affect them.
What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.
Whether it's data or marketing dollars, there should be no surprises when you partner with a company.
The Food and Drug Administration regulates more than a third of the U.S. economy. And its new commissioner, Scott Gottlieb, is trying to shake up how it does so.
In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.
Four data aces share their backgrounds, inspirations, and guiding philosophies
As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.
New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.
Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.
Drugmakers inconsistently share clinical trial data; AstraZeneca's share price falls after Mystic results; some pregnancy apps share info with marketers
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
As drugmakers hire economists and pharmacologists to better grapple with big data, how can ad agencies ensure they're not left behind?
Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug